Ferry J A, Young R H, Scully R E
James Homer Wright Pathology Laboratories of the Massachusetts General Hospital, Boston 02114, USA.
Am J Surg Pathol. 1997 May;21(5):590-8. doi: 10.1097/00000478-199705000-00013.
We report the cases of six men, 40 to 89 years of age, with testicular (6 cases) or epididymal (1 case) plasmacytoma. Patients presented with a mass in five cases. One tumor was found during evaluation of progressive myeloma. In the final case, the testicular lesion was identified when the patient presented with pathologic fractures. Gross inspection revealed discrete or, less often, ill-defined lesions. Microscopic examination disclosed masses of atypical plasma cells, including binucleated and multinucleated cells and, occasionally, anaplastic cells that obliterated the underlying parenchyma or invaded between seminiferous or epididymal tubules. Immunohistochemical stains on paraffin sections in five cases showed tumor cell expression of monotypic cytoplasmic immunoglobulin. The cells were positive for the leukocyte common antigen (CD45) in three of five cases. All four cases tested were negative for B (CD20) and T (CD3) cell specific antigens and for CD30 and placental alkaline phosphatase. Expression of CD43, CD45RO, and epithelial membrane antigen was found in three, two, and one of four cases respectively. All the patients also had plasma cell neoplasia distant from the testis, identified before (3 cases), concurrent with (3 cases) or after (1 case) the testicular or epididymal plasmacytoma. In one patient a plasmacytoma developed in the contralateral testis three years later; he was alive with plasma cell myeloma 51 months after diagnosis. Another had a plasmacytoma in the contralateral epididymis 8 years later; he also had a nasal cavity plasmacytoma and multiple subcutaneous plasmacytomas, and was alive and well after 26 years. One additional patient was alive with myeloma 6 months later, and four final patients died between 2 months and 3 years after orchiectomy. Three of the four consultation cases in this series were submitted with diagnoses of spermatocytic seminoma, anaplastic seminoma and lymphoma. The diagnosis of plasmacytoma should be borne in mind when examining testicular or paratesticular tumors with a diffuse pattern without glandular differentiation, particularly in men 40 years of age or older.
我们报告了6例年龄在40至89岁之间的男性病例,均患有睾丸浆细胞瘤(6例)或附睾浆细胞瘤(1例)。5例患者表现为肿块。1例肿瘤是在评估进展性骨髓瘤时发现的。在最后1例中,患者出现病理性骨折时发现了睾丸病变。大体检查显示为边界清晰的病变,少数情况下边界不清。显微镜检查发现大量非典型浆细胞,包括双核和多核细胞,偶尔还有间变细胞,这些细胞破坏了下方的实质组织或侵入生精小管或附睾小管之间。5例石蜡切片的免疫组织化学染色显示肿瘤细胞表达单型细胞质免疫球蛋白。5例中有3例细胞白细胞共同抗原(CD45)呈阳性。检测的4例均对B(CD20)和T(CD3)细胞特异性抗原以及CD30和胎盘碱性磷酸酶呈阴性。4例中分别有3例、2例和1例表达CD43、CD45RO和上皮膜抗原。所有患者还患有远离睾丸的浆细胞瘤,在睾丸或附睾浆细胞瘤之前(3例)、同时(3例)或之后(1例)被发现。1例患者3年后对侧睾丸发生浆细胞瘤;诊断后51个月时,他患有浆细胞骨髓瘤且存活。另1例8年后对侧附睾发生浆细胞瘤;他还患有鼻腔浆细胞瘤和多发性皮下浆细胞瘤,26年后仍存活且状况良好。另有1例患者6个月后患有骨髓瘤且存活,最后4例患者在睾丸切除术后2个月至3年之间死亡。本系列4例会诊病例中有3例提交时诊断为精母细胞性精原细胞瘤、间变性精原细胞瘤和淋巴瘤。在检查无腺管分化的弥漫性睾丸或睾丸旁肿瘤时,应考虑浆细胞瘤的诊断,尤其是40岁及以上的男性。